英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
YO-01027
|
209984-56-5 |
YO127
|
YO01027;N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺;Γ-分泌酶抑制剂;YO-01027-分泌酶抑制剂;二苯并氮卓,Γ-SECRETASE 抑制剂;二苯并氮卓;CS-366;YO-01027;YO01027;DIBENZAZEPINE;DESHYDROXY LY 411575;DBZ
|
C26H23F2N3O3 |
463.49 | |
YH239-EE
|
1364488-67-4 |
YH239-EE
|
|
C25H27Cl2N3O4 |
504.42 | |
XL-888
|
1149705-71-4 |
XL888
|
XL888;XL-888;XL 888;CS-2629;CS-831
|
C29H37N5O3 |
503.63578 | |
BMS-863233 (XL-413)
|
1169562-71-3 |
XL413 (BMS-863233)
|
8-氯-2-(2S)-2-吡咯烷基苯并呋喃并[3,2-D]嘧啶-4(3H)-酮盐酸盐;XL413(BMS-863233);CS-1062;BMS-863233;BMS863233;BMS 863233;XL-413;XL413;XL 413.;XL413.HCL
|
C14H13Cl2N3O2 |
326.17792 | |
WZ8040
|
1214265-57-2 |
WZ84
|
CS-471;WZ-8040;WZ 8040;N-[3-[[5-氯-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]硫基]苯基]-2-丙烯酰胺
|
C24H25ClN6OS |
481.02 | |
WZ3146
|
1214265-56-1 |
WZ3146
|
N-[3-[[5-氯-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氧基]苯基]-2-丙烯酰胺;MZ-3146;CS-525;WZ 3146;WZ-3146;WZ3146;WZ3146;WZ 3146
|
C24H25ClN6O2 |
464.96 | |
VX-765(Belnacasan)
|
851091-96-8 |
1G, 5G, 1G, 1KG
|
VX-765
|
508.99502 | ||
VX-745
|
209410-46-8 |
VX-745
|
CS-1918;NEFLAMAPIMOD;VX 745;VX-745游离态;5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基)-6H-嘧啶并[1,6-B]哒嗪-6-酮;209410-46-8;5-(2,6-B]哒嗪-6-酮(VX745);5-(2,6-b]哒嗪-6-酮
|
C19H9Cl2F2N3OS |
436.26 | |
VX-222
|
1026785-59-0 |
VX-222
|
CS-481;VCH222;VX 222;VCH 222;VCH-222;VX-222;5-(3,3-二甲基-1-丁炔-1-基)-3-[(顺式-4-羟基环己基)[(反式-4-甲基环己基)羰基]氨基]-2-噻吩甲酸
|
C25H35NO4S |
445.6147 | |
VU 0364770
|
61350-00-3 |
VU 36477
|
VU0364770;VU-0364770;N-(3-氯苯基)吡啶甲酰胺;N-(3-氯苯基)-2-吡啶甲酰胺;VU 0364770 100MG
|
C12H9ClN2O |
232.66566 | |
VU 0364439
|
1246086-78-1 |
VU 364439
|
VU 0364439;VU0364439;VU-0364439;VU 0364439 10MG;CS-629;N-[3-氯-4-[[(2-氯苯基)氨基]磺酰基]苯基]-2-吡啶甲酰胺
|
C18H13Cl2N3O3S |
422.28512 | |
VU 0357121
|
433967-28-3 |
VU 357121
|
4-丁氧基-N-(2,4-二氟苯基)苯甲酰胺;4-丁氧基-N-(2;4-二氟苯基)苯甲酰胺
|
C17H17F2NO2 |
305.319186 | |
VS-5584
|
1246560-33-7 |
VS-5584
|
SB-2343;VS5584;VS 5584;SB2343;SB 2343;CS-875;5-[8-甲基-9-异丙基-2-(4-吗啉基)-9H-嘌呤-6-基]-2-嘧啶胺(VS-5584);VS-5584 (SB2343);VS-5584;VS5584;VS 5584;5-(9-ISOPROPYL-8-METHYL-2-MORPHOLINO-9H-PURIN-6-YL)PYRIMIDIN-2-AMINE;5-[8-甲基-9-异丙基-2-(4-吗啉基)-9H-嘌呤-6-基]-2-嘧啶胺
|
C17H22N8O |
354.40958 | |
BI6727 (Volasertib)
|
755038-65-4 |
Volasertib (BI 6727)
|
CS-552;VOLASERTIB (BI 6727);BI 6727;BI-6727;BI6727;伏拉塞替 250MG;伏拉塞替;N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基];N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基]-4-[[(7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺;BI 6727;BI-6727;BI6727;CS-1612
|
C34H50N8O3 |
618.8126 | 813-258-1 |
Vinflunine Tartrate
|
1201898-17-0 |
长春氟宁酒石酸盐
|
长春氟宁酒石酸盐
|
C49H60F2N4O14 |
967.03 | |
Vinblastine
|
865-21-4 |
长春质碱
|
长春碱;长春花碱对照品;长春花碱;硫酸长春碱 94% BP99;長春鹼;长春质碱;长春碱(标准品);长春碱,长春质碱;长春花碱,长春碱
|
C46H58N4O9 |
810.97 | 212-734-0 |
Varlitinib
|
845272-21-1 |
ARRY334543
|
ARRY-334543;ARRY 334543;ARRY334543;CS-663;VARLITINIB (ARRY-334543;ASLAN001);ARRY-334543;ARRY334543
|
C22H19ClN6O2S |
466.94326 | |
4-(4-Hydroxy-3-methoxyphenyl)-2-butanone
|
122-48-5 |
姜酮
|
姜酮对照品;4-(4-羟基-3-甲氧基苯基)-2-丁酮;4-4-羟基-3-甲氧基;4-4-羟基-3-甲氧基丁-2-酮;天然姜酮;薑酮;姜酮(标准品);4-(4-羟基-3-甲氧基苯)-2-丁酮
|
C11H14O3 |
194.23 | 204-548-3 |
UMI-77
|
518303-20-3 |
UMI-77
|
CS-1799;UMI-77;UMI 77;UMI77;2-((4-(4-溴苯基磺酰氨基)-1-羟基萘-2-基)硫基)乙酸
|
C18H14BrNO5S2 |
468.34146 | |
UK-383367
|
348622-88-8 |
UK 383367
|
5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺;UK-383367 (UK 383367)
|
C15H24N4O4 |
324.37546 |